Nuformix PlcNuformix PlcNuformix Plc

Nuformix Plc

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪4.59 M‬GBP
−0.004GBP
‪−3.64 M‬GBP
0.00GBP
‪1.82 B‬
Beta (1Y)
0.06

About Nuformix Plc


Headquarters
London
Founded
2008
ISIN
GB00BYW79Y38
FIGI
BBG00BNG11S0
Nuformix Plc is a pharmaceutical development company, which targets unmet medical needs in fibrosis and oncology via drug repurposing. It focuses on cocrystal technology. Its products include NXP001, NXP002, and NXP004. The company was founded by Joanne Holland, Daniel Gooding, and David Tapolczay in 2008 and is headquartered in London, the United Kingdom.

Check out other big names from the same industry as NFX.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of NFX is 0.275 GBX — it has increased by 4.35% in the past 24 hours. Watch Nuformix Plc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange Nuformix Plc stocks are traded under the ticker NFX.
NFX stock has risen by 0.97% compared to the previous week, the month change is a 118.18% rise, over the last year Nuformix Plc has showed a 323.08% increase.
NFX reached its all-time high on Jun 24, 2019 with the price of 14.894 GBX, and its all-time low was 0.040 GBX and was reached on Nov 4, 2024. View more price dynamics on NFX chart.
See other stocks reaching their highest and lowest prices.
NFX stock is 50.00% volatile and has beta coefficient of 0.06. Track Nuformix Plc stock price on the chart and check out the list of the most volatile stocks — is Nuformix Plc there?
Today Nuformix Plc has the market capitalization of ‪4.59 M‬, it has decreased by −17.02% over the last week.
Yes, you can track Nuformix Plc financials in yearly and quarterly reports right on TradingView.
Nuformix Plc is going to release the next earnings report on Dec 3, 2025. Keep track of upcoming events with our Earnings Calendar.
NFX net income for the last half-year is ‪−376.67 K‬ GBP, while the previous report showed ‪−3.40 M‬ GBP of net income which accounts for 88.92% change. Track more Nuformix Plc financial stats to get the full picture.
No, NFX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, NFX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Nuformix Plc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Nuformix Plc technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Nuformix Plc stock shows the buy signal. See more of Nuformix Plc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.